Alan Miller
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call.
It is now my pleasure to introduce your host, General Joseph Franklin, Chairman of the Board for Frequency Electronics. Thank you. Mr. Franklin, you may begin
Thanks, Joe, and good afternoon, everyone. Revenues for fiscal year 2012, which ended last April 30, was $63.6 million compared to $53.2 million last year. The 20% year-over-year increase in revenues was generated from satellite payload programs, which accounted for almost 50% of fiscal 2012 revenues. Revenues were derived approximately equally from U.S. government and commercial satellite programs. All of the satellite payload work occurs in our FEI-NY segment.
Combined revenues from our other 2 segments, FEI-Zyfer and Gillam-FEI, were 5% lower than last year. Only 2 months of revenues from our recently acquired Elcom Technologies, or FEI-Elcom, are included in the revenues of the FEI-NY segment and they did not have a meaningful impact for fiscal year 2012.
Over 2/3 of our current backlog consists of satellite payload programs. Consequently, we expect satellite payloads to remain our dominant business area into the future. However, we also expect to see meaningful growth in our U.S. Government/DOD area during fiscal 2013.
Also, sales for fiscal 2012 were $39 million, compared with $33.3 million last year, though the higher revenue enabled us to achieve a 23% increase in gross margin to $24.6 million from $20 million. Gross margin rate for fiscal 2012 was 38.7%, an improvement from last year's 37.5%. Note that the gross margin rate for the FEI-NY operations exceeded 40%. At this level of revenues and with a favorable product mix, we expect to achieve a gross margin rate of 40% or better in fiscal year 2013.
As noted previously, increased revenues do not cause a comparable increase in operating costs. For fiscal 2012, our SG&A and our R&D spending combined increased by 7% compared to the 20% increase in revenues. Fiscal 2012 SG&A was $13.8 million compared to $11.4 million in the year-ago period, and both amounts are less than 22% of revenues.
R&D spending was $3.9 million in fiscal 2012 or about 60% of revenues, compared to $5.1 million or 10% of revenues in fiscal 2011.
As we have discussed previously, many of our R&D resources are being applied to funded development under several contracts and those costs are included in cost of sales. However, any new products or technologies that may result from such development remain Frequency's proprietary property.
As a result of improved gross margin and the modest increases in operating costs, we were able to almost double our operating profits to $6.9 million in fiscal 2012 from $3.5 million in the last year. Our operating profit was 11% of consolidated revenue, compared to less than 7% in fiscal 2011. Other income, which consists of investment income offset by interest and other expenses, netted to an expense of $121,000 compared to income of $105,000 1 year ago. Now the press release will detail it a little bit more, but other income this year included a $700,000 gain related to the step acquisition of Elcom. This gain partially offset previously recorded equity losses, impairment charges and the expenses related to the acquisition of Elcom in February of this past year. This yields nearly a 90% increase in pretax income to $6.8 million compared to $3.6 million last year.
As we did last year and after noting the significant increase in profitability in fiscal 2012, as well as our prospects for continued high level of performance, we determined that we would be able to realize the tax benefits from the future deductibility of more items in our deferred tax assets. Thus, in accordance with GAAP accounting criteria, we reversed $3.1 million of a $4.6 million deferred tax valuation allowance resulting in a net tax benefit of $560,000. Last year's tax benefit included a $3.7 million reversal of the valuation allowance, resulting in a larger benefit last year of $2.4 million.
Remaining valuation allowance is primarily related to deferred tax assets of our foreign subsidiaries and we do not anticipate further reversals in the near future. The end result is net income for the full fiscal year of 2012 of $7.4 million, compared to $6 million last year; $0.86 diluted share -- per share in fiscal 2012, compared to $0.72 last year.
For the year, we generated positive operating cash flow of $2.1 million, and cash and marketable securities are at $22.4 million. This is after borrowing $6.1 million under our credit line at a very favorable interest rate rather than liquidate a portion of our investment portfolio, which has a higher yield.
Our funded backlog at the end of April was about $57 million, and about 60% of that backlog is realizable in the next 12 months. This time, I'll turn it -- the call over to Martin Bloch and we'll be back to talk you a little bit later with your questions.